Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the actual posting from April to May:
STOCK (Ticker) MAY07 APR07 Change
Pfizer (PFE) 52.12M 50.28M 3.6%
Merck (MRK) 22.55M 18.68M 20.6%
Johnson & Johnson (JNJ) 16.16M 14.47M 11.7%
Abbott Labs (ABT) 16.39M 14.90M 10%
Wyeth (WYE) 10.37M 9.61M 7.9%
Eli Lilly (LLY) 14.07M 10.95M 28.5%
Bristol-Myers (BMY) 23.85M 18.75M 27.2%
Schering-Plough (SGP) 15.27M 14.09M 8.3%
Medtronic (MDT) 15.19M 13.81M 9.9%
Boston Scientific (BSX) 24.06M 21.65M 11.1%
St. Jude MEdical (STJ) 7.13M 5.85M 21.8%
Quest Diagnost. (DGX) 17.54M 16.57M 11.1%
lower short interest…..
GlaxoSmithkline (GSK) 5.15M 4.66M -11%
Genentech (DNA) 8.16M 8.76M -6.8%
Zimmer Holdings (ZMH) 4.13M 5.00M -17%
Labcorp (LH) 3.21M 3.34M -3.9%
Jon C. Ogg
May 22, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Cash Back Credit Cards Have Never Been This Good
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.